These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17393430)

  • 1. Phosphatidylcholine-specific phospholipase C and ROS were involved in chicken blastodisc differentiation to vascular endothelial cells.
    Zhao J; Zhao B; Wang W; Huang B; Zhang S; Miao J
    J Cell Biochem; 2007 Oct; 102(2):421-8. PubMed ID: 17393430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PC-PLC blocked the survival of mouse neural cells by up-regulating the expression of integrin beta4 and Rb.
    Lv X; Wang N; Su L; Zhang S; Miao J
    Dev Neurosci; 2006; 28(6):499-504. PubMed ID: 17028427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylcholine-specific phospholipase C, p53 and ROS in the association of apoptosis and senescence in vascular endothelial cells.
    Cheng Y; Zhao Q; Liu X; Araki S; Zhang S; Miao J
    FEBS Lett; 2006 Sep; 580(20):4911-5. PubMed ID: 16920112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressing phosphatidylcholine-specific phospholipase C and elevating ROS level, NADPH oxidase activity and Rb level induced neuronal differentiation in mesenchymal stem cells.
    Wang N; Xie K; Huo S; Zhao J; Zhang S; Miao J
    J Cell Biochem; 2007 Apr; 100(6):1548-57. PubMed ID: 17211851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells.
    Zhang L; Li HY; Li H; Zhao J; Su L; Zhang Y; Zhang SL; Miao JY
    J Cell Physiol; 2011 Jun; 226(6):1694-701. PubMed ID: 21413027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D609 inhibits progression of preexisting atheroma and promotes lesion stability in apolipoprotein e-/- mice: a role of phosphatidylcholine-specific phospholipase in atherosclerosis.
    Zhang L; Zhao J; Su L; Huang B; Wang L; Su H; Zhang Y; Zhang S; Miao J
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):411-8. PubMed ID: 20139365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of apoptosis by inhibition of phosphatidylcholine-specific phospholipase C in vascular endothelial cells.
    Miao JY; Kaji K; Hayashi H; Araki S
    Endothelium; 1997; 5(4):231-9. PubMed ID: 9588815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting effects of phosphatidylinositol- and phosphatidylcholine-specific phospholipase C on apoptosis in cultured endothelial cells.
    Liu X; Zhao Q; Araki S; Zhang S; Miao J
    Endothelium; 2006; 13(3):205-11. PubMed ID: 16840176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylmercury-induced toxicity is mediated by enhanced intracellular calcium through activation of phosphatidylcholine-specific phospholipase C.
    Kang MS; Jeong JY; Seo JH; Jeon HJ; Jung KM; Chin MR; Moon CK; Bonventre JV; Jung SY; Kim DK
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):206-15. PubMed ID: 16854443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC alpha depletion in RAW264.7 macrophages following microbial/IFNgamma stimulation is PC-PLC-mediated.
    von Knethen A; Brüne B
    Antioxid Redox Signal; 2005; 7(9-10):1217-22. PubMed ID: 16115026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatidylcholine-specific phospholipase C activation in epithelial ovarian cancer cells.
    Spadaro F; Ramoni C; Mezzanzanica D; Miotti S; Alberti P; Cecchetti S; Iorio E; Dolo V; Canevari S; Podo F
    Cancer Res; 2008 Aug; 68(16):6541-9. PubMed ID: 18701477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiviral, antitumoural xanthate D609 is a competitive inhibitor of phosphatidylcholine-specific phospholipase C.
    Amtmann E
    Drugs Exp Clin Res; 1996; 22(6):287-94. PubMed ID: 9034754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis mediated by phosphatidylcholine-specific phospholipase C is associated with cAMP, p53 level, and cell-cycle distribution in vascular endothelial cells.
    Du C; Zhao Q; Araki S; Zhang S; Miao J
    Endothelium; 2003; 10(3):141-7. PubMed ID: 13129817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of phosphatidylcholine-specific phospholipase C and basic fibroblast growth factor in the neural differentiation of mesenchymal stem cells in vitro.
    Wang N; Sun C; Huo S; Zhang Y; Zhao J; Zhang S; Miao J
    Int J Biochem Cell Biol; 2008; 40(2):294-306. PubMed ID: 17890138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
    Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
    Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature.
    Adibhatla RM; Hatcher JF; Gusain A
    Neurochem Res; 2012 Apr; 37(4):671-9. PubMed ID: 22101393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Phosphatidylcholine-Specific Phospholipase C Interferes with Proliferation and Survival of Tumor Initiating Cells in Squamous Cell Carcinoma.
    Cecchetti S; Bortolomai I; Ferri R; Mercurio L; Canevari S; Podo F; Miotti S; Iorio E
    PLoS One; 2015; 10(9):e0136120. PubMed ID: 26402860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
    Larsen EC; Hatcher JF; Adibhatla RM
    Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of alveolar macrophage respiratory burst by H(2)O(2) is prevented by phosphatidylcholine-specific phospholipase C inhibitor Tricyclodecan-9-yl-xanthate (D609).
    Girón-Calle J; Srivatsa K; Forman HJ
    J Pharmacol Exp Ther; 2002 Apr; 301(1):87-94. PubMed ID: 11907161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells.
    Singh AT; Radeff JM; Kunnel JG; Stern PH
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):201-8. PubMed ID: 11018472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.